Not all chronic pain is the same. Learn how to identify the type you have—and discover which treatments, including ...

Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date ...

More information: Alan Y. Hsu et al, Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes, JAMA Ophthalmology (2025). DOI: 10.1001/jamaophthalmol.2025.0349 ...

Painful diabetic peripheral neuropathy is often resistant to conventional medications, leaving patients with persistent pain and functional limitations. The Inspire Study enrolled individuals with the ...

With advances in high-resolution imaging, mass spectrometry and machine-learning-assisted data analysis, spatial-proteomics researchers are mapping and tracking proteins with increasing detail at ...

Patients with diabetes taking a semaglutide medication face a higher risk of NAION, a potentially debilitating ophthalmic condition. Semaglutide medication use is linked with a greater risk of ...

People who have diabetic neuropathy, nerve damage that reduces sensitivity to pain, are more vulnerable to diabetic blisters. Peripheral artery disease is also thought to play a role. Given the ...

In addition to lifestyle choices and neuropathy, people with diabetes sometimes take medications that can slow gut mobility and cause constipation. Talk with your doctor about the side effects of ...

Ultimately, if type 2 diabetes is not treated, it can lead to diabetic neuropathy, which means damage to the nerves. The Mayo Clinic advises that peripheral neuropathy, the most common type of ...